Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nearly A Quarter Of Diabetes Patients Altered Therapy In Part D Gap – Study

Executive Summary

Twenty-three percent of a large sample of Medicare Part D enrollees taking oral drugs for diabetes changed their medication use when they reached the gap in coverage, according to a study released by the Kaiser Family Foundation Aug. 21

You may also be interested in...

Life In The Donut Hole: OIG Offers Glimpse Into Part D Prescription Habits

In a study of Medicare Part D beneficiaries who entered the coverage gap and had no financial assistance, the HHS Office of Inspector General finds 69 percent decreased the number of drugs purchased.

Part D Rx Use Shows “Little Change” As Enrollees Enter Coverage Gap, CMS Says

CMS gives first glimpse at the kind of Part D drug claims data that will become available to researchers in December.

Economic Forecast For Pharma: Winter Advisory Ahead

Pharma has weathered its share of economic downturns, and the industry is widely regarded as one investors bunker down with during a recession-patients always need medicines, the theory goes. But this time around, the familiar reassurances sound a little less comforting

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts